The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Abeona Therapeutics Inc shares valued at $32,683 were sold by Crombez Eric on Aug 14 ’25. At $6.93 per share, Crombez Eric sold 4,718 shares. The insider’s holdings dropped to 42,427 shares worth approximately $0.29 million following the completion of this transaction.
Also, Vazzano Joseph Walter sold 15,000 shares, netting a total of over 110,358 in proceeds. Following the sale of shares at $7.36 each, the insider now holds 462,666 shares.
Before that, Vazzano Joseph Walter had added 15,000 shares to its account. In a trade valued at $110,358, the Officer bought Abeona Therapeutics Inc shares for $7.36 each.
Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early March. As of July 03, 2024, H.C. Wainwright has initiated its “Buy” rating for ABEO. Earlier on May 30, 2024, Stifel initiated its rating. Their recommendation was “a Buy” for ABEO stock.
Analyzing ABEO Stock Performance
On last trading session, Abeona Therapeutics Inc [NASDAQ: ABEO] plunged -2.95% to $6.9. The stock’s lowest price that day was $6.89, but it reached a high of $7.15 in the same session. During the last five days, there has been a drop of approximately -1.43%. Over the course of the year, Abeona Therapeutics Inc shares have jumped approximately 25.11%. Shares of the company reached a 52-week high of $7.54 on 08/15/25 and a 52-week low of $3.93 on 04/09/25.
Support And Resistance Levels for Abeona Therapeutics Inc (ABEO)
According to the 24-hour chart, there is a support level at 6.81, which, if violated, would cause prices to drop to 6.72. In the upper region, resistance lies at 7.07. The next price resistance is at 7.24. RSI (Relative Strength Index) is 54.66 on the 14-day chart, showing neutral technical sentiment.
Is Abeona Therapeutics Inc subject to short interest?
Stocks of Abeona Therapeutics Inc saw a sharp rise in short interest on 2025-08-15 jumping by 0.33 million shares to 8.81 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 8.48 million shares. A jump of 3.79% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.86 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.86.
Which companies own the most shares of Abeona Therapeutics Inc (ABEO)?
In terms of Abeona Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, up nearly 153.16% from the previous closing price of $7.11. Analysts anticipate Abeona Therapeutics Inc stock to reach 20 by 2025, with the lowest price target being 16. In spite of this, 2 analysts ranked Abeona Therapeutics Inc stock as Buy at the end of 2025. On November 11, 2020, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and upgraded coverage with a $4.
